Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000628:therapy*; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D012673:Semustine / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000628:therapy*
D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D012673:Semustine; D003606:Dacarbazine